Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.
about
QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease.Assessing the viability of long-acting β2-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective.Indacaterol for the treatment of chronic obstructive pulmonary disease.
P2860
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.
@en
type
label
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.
@en
prefLabel
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation.
@en
P2860
P1476
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation
@en
P2093
Maria Gabriella Matera
Mario Cazzola
P2860
P304
P356
10.1517/17425255.2014.865723
P407
P577
2013-12-03T00:00:00Z